Prism Medico and Pharmacy share news, announcements and annual reports
Share price at the BSE close on 30 Oct 2026. Previous close ₹35.80.
30 Oct: open ₹34.52, high ₹36.60, low ₹34.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹48 Cr4,315th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 42,981
Prism Medico and Pharmacy share news and announcements
817 announcements, routine notices left out, newest first. Page 3 of 17.
Jan 2025
4 Jan · Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Nov 2024
14 Nov · Details Of Related Party Transactions (RPT'S) As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
14 Nov · Intimation As Per Regulation 6(1) And Regulation 30 Read With Clause 7 Of Para A Of Schedule III Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
14 Nov · Results
7 Nov · Board meeting
Meeting on 14 Nov 2024: quarterly results
Oct 2024
21 Oct · Undertaking Of Functional Website.
15 Oct · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
7 Oct · Compliance-57 (5) : intimation after the end of quarter
1 Oct · Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Sep 2024
5 Sep · Annual Report For The Financial Year 2023-2024.
2 Sep · Board meeting
Meeting on 5 Sep 2024: annual general meeting
Aug 2024
7 Aug · Board meeting
Meeting on 14 Aug 2024: quarterly results
Jul 2024
29 Jul · Undertaking Of Functional Website.
20 Jul · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
8 Jul · Intimation Under Regulation 57(5) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015.
8 Jul · Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Jun 2024
5 Jun · Details Of Related Party Transactions (RPT'S) As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
May 2024
29 May · Board meeting
22 May · Board meeting
Meeting on 29 May 2024: audited results3 May · Board meeting
Meeting on 3 May 2024
Apr 2024
29 Apr · Submission Of Compliance Certificate Certifying The Maintenance Of Physical And Electronic Share Transfer Facility As Per Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 During The Financial Year Ended 31St March, 2024.
29 Apr · Submission Of Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March 2024.
20 Apr · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
1 Apr · Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015.
1 Apr · Compliance-57 (5) : intimation after the end of quarter
Feb 2024
5 Feb · Board meeting
Meeting on 13 Feb 2024: quarterly results
Jan 2024
19 Jan · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
5 Jan · Compliance-57 (5) : intimation after the end of quarter
5 Jan · Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015.
Dec 2023
22 Dec · Legal
Exchange has sought clarification from Prism Medico and Pharmacy Ltd on December 22, 2023 with reference to significant movement in price, in order to ensure that investors have latest ....
Nov 2023
8 Nov · Details Of Related Party Transactions (RPT'S) As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.